MOESM2 of Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study CalabreseJoseph JinNa JohnsonBrian SuchPedro BakerRoss MaderaJessica HertelPeter OttingerJocelyn AmatniekJoan KawasakiHiroaki 2018 Additional file 2: Table S2. Change from baseline to week 52 in extrapyramidal symptoms scales during AOM 400 maintenance phase.